Cargando…
Real-World Evaluation of a Pharmacoinvasive Strategy for STEMI in Latin America: A Cost-Effective Approach with Short-Term Benefits
PURPOSE: While pharmacoinvasive strategy (PI) is a safe and effective approach whenever access to primary percutaneous intervention (pPCI) is limited, data on each strategy’s economic cost and impact on in-hospital stay are scarce. The objective is to compare the cost-effectiveness of a PI with that...
Autores principales: | Arias-Mendoza, Alexandra, Ortega-Hernández, Jorge A, Araiza-Garaygordobil, Diego, González-Pacheco, Héctor, Martínez-García, Mireya, Hernández-Lemus, Enrique, Gopar-Nieto, Rodrigo, Sandoval-Aguilar, Tomás Tadeo, Sierra-Lara Martinez, Daniel, Mendoza-García, Salvador, Altamirano-Castillo, Alfredo, Briseño-de-la-Cruz, José Luis, Ortega-Hernández, Midori Alondra, Soliz-Uriona, Luis Alejandro, Gaspar-Hernández, Jorge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644829/ https://www.ncbi.nlm.nih.gov/pubmed/38023623 http://dx.doi.org/10.2147/TCRM.S432683 |
Ejemplares similares
-
Response to “Pharmacoinvasive strategy: An essential tool to avoid the Reperfusion Paradox in STEMI networks”
por: Gopar-Nieto, Rodrigo, et al.
Publicado: (2021) -
Pharmacoinvasive Strategy vs Primary Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction: Results From a Study in Mexico City
por: Araiza-Garaygordobil, Diego, et al.
Publicado: (2020) -
Invasive Phenoprofiling of Acute-Myocardial-Infarction-Related Cardiogenic Shock
por: Ortega-Hernández, Jorge A., et al.
Publicado: (2023) -
Analysis of immortal-time effect in post-infarction ventricular septal defect
por: González-Pacheco, Héctor, et al.
Publicado: (2023) -
Application of the SCAI classification to admission of patients with cardiogenic shock: Analysis of a tertiary care center in a middle-income country
por: González-Pacheco, Héctor, et al.
Publicado: (2022)